Frazier Healthcare Partners, a Seattle-based private equity firm focused exclusively on the healthcare sector, announced its investment in Knipper Health, a leading therapy initiation partner. Concurrent with the announcement, Willis Chandler has been appointed as President and Chief Executive Officer of Knipper Health.
Knipper helps patients start treatment faster by embedding digital enrollment, real-time benefit investigation, and automated prior authorization directly into provider workflows, which are connected to flexible, scalable fulfillment options, including specialty pharmacy, direct-to-patient cash, samples, free-goods and 3PL provider-administered programs. By customizing delivery to patient needs and optimizing gross-to-net performance, Knipper helps improve outcomes for patients and Biopharma partners alike.
Mr. Chandler is an accomplished healthcare executive with deep experience in pharmaceutical services and brings a strong track record of operational excellence and strategic leadership. Most recently, Mr. Chandler served as Executive in Residence at Frazier, where he supported investments and growth initiatives across the pharmaceutical services ecosystem. Prior to Frazier, Chandler served in several senior leadership positions. Most recently, he was President of Global Pharma Services at Cencora (formerly AmerisourceBergen), overseeing a diverse portfolio including hub services, consulting, outsourced commercial operations, and distribution. Prior to Cencora, Chandler co-founded Shields Health Solutions, a leading specialty pharmacy integrator for health systems, and held leadership roles at CVS Health and in Health Systems and Provider practices.
Also Read: Appian Named to AIFinTech100 2025 for AI in Finance
“Knipper is at the forefront of transforming therapy initiation through a data-enabled, patient-centric platform,” said Nathan Every, General Partner at Frazier. “We are excited to partner with Willis and the Knipper team to build on the Company’s strong foundation and accelerate its growth. Willis’s experience across commercial pharma services makes him well-suited to lead Knipper through its next chapter.”
“I’m thrilled to join Knipper at a time when we are redefining how quickly and efficiently patients begin therapy,” said Mr. Chandler. “By embedding real-time medical and pharmacy automation at the point of care, aligning fulfillment to patient needs, and powering decisions with actionable data, I look forward to accelerating our mission to create a faster, more efficient path from order to therapy.”
SOURCE: Businesswire